No Survival Benefit in Transplanting Stable LVAD Patients (Status 4)

Files

Authors

Renzo Loyaga-Rendon, Corewell Health West
Sangjin Lee, Corewell Health West
Nabin Manandhar-Shrestha
Deepak Acharya
Marzia Leacche

Description

The Heart Transplant (HT) allocation system prioritizes transplantation based on the likelihood of waitlist mortality (urgency) and doesn't incorporate post-transplant survival. Stable LVAD-supported patients have a low priority for HT. Currently, a new allocation system is being developed that would increase the chances of transplanting stable LVAD-supported patients. Our objective was to analyze the net benefit of receiving HT on LVAD patients according to their listing and transplant status.

Publication Date

5-9-2025

Disciplines

Cardiology

Recommended Citation

Loyaga-Rendon R, Lee S, Manandhar-Shrestha N, Acharya D, Leacche M. No survival benefit in transplanting stable LVAD patients (status 4). Presented at: Research Day Corewell Health West; 2025 May 9; Grand Rapids, MI.

Comments

2025 Research Day Corewell Health West, Grand Rapids, MI, May 9, 2025. Abstract 1861